Canadian Medical Cannabis Provider Expanding into US Market Through RTO
Source: Streetwise Reports  (7/25/17)
A company with Canadian medical cannabis provider Aphria's backing is doing a reverse takeover on the Canadian Securities Exchange and expects to begin trading on July 26. More >

Silver Green Alert: One of the Best Buying Opportunities for Years
Source: Clive Maund for Streetwise Reports  (7/23/17)
Precious metals are on the threshold of a barn-burner rally, says technical analyst Clive Maund. More >

Gold: It's Time!
Source: Lior Gantz for Streetwise Reports  (7/23/17)
Lior Gantz, founder of Wealth Research Group, believes that fundamentals for precious metals have been confirmed and expects a major rally. More >

Gold: Add a Zero to Your Net Worth
Source: Tom Beck for Streetwise Reports  (7/23/17)
Tom Beck, founder of Portfolio Wealth Global, explains why he believes market forces are aligning for a powerful gold trend. More >

Jack Chan's Weekly Gold and Silver Market Update
Source: Jack Chan for Streetwise Reports  (7/22/17)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets.
More >

Are US Equities in a Bubble?
Source: Rudi Fronk and Jim Anthony for Streetwise Reports  (7/22/17)
Rudi Fronk and Jim Anthony, the cofounders of Seabridge Gold, examine the role of risk when trying to differentiate between a bull market and a bubble. More >

Explorer on Target to Issue Upgraded Resource by Early Fall
Source: Streetwise Reports  (7/20/17)
Southern Silver Exploration's core drill program at Cerro Las Minitas in Durango, Mexico, is coming to an end and the company sees the potential for a substantial resource upgrade, say Robert Macdonald, Southern Silver's VP for Exploration, and Jay Oness, VP for Investor Relations. In this interview with Streetwise Reports, they also discuss the recently acquired additional claims, the Oro project in New Mexico and the JV with Electrum. More >

Acquisition of Canadian Gold Company Contributes to Pressure on Stock
Source: Streetwise Reports  (7/20/17)
In resuming coverage of Eldorado Gold following the acquisition of Integra Gold and its Lamaque property, BMO Capital Markets analyst Andrew Kaip looked at the impact of the move, as well as at other factors pressuring Eldorado stock. More >

Nevada and Canada Miner Reports Q2 Production Up 94%
Source: Streetwise Reports  (7/20/17)
Preliminary Q2 operating results show production up 94% and sales up 107%, a record for this company's Nevada and Canadian mines, news that was noted by a trio of industry analysts. More >

Gold in Japan, a Nation Unexplored for Many Years
Source: Bob Moriarty for Streetwise Reports  (7/20/17)
Bob Moriarty of 321 Gold profiles a company that may have an inside edge in gold mining in Japan. More >

DNA-Based Compound Shuts Down Seasonal Flu in Preclinical Study
Source: Streetwise Reports  (7/19/17)
A U.S. biotech developing vaccines to fight a number of infectious diseases has generated promising preclinical results with a platform therapy targeting influenza, and expects to enter the clinic with a similar platform compound targeting Ebola in 2018. More >

Molori Energy 'Ready to Explode Higher'
Source: Bob Moriarty for Streetwise Reports  (7/19/17)
A novel use of fracking could ramp up production in the conventional North Texas oil wells that Molori Energy holds in a JV with Ponderosa Energy, says Bob Moriarty of 321 Energy. More >

Progress in Pain Control and Liver Disease Programs Spurs Rise in Company's Rating
Source: Streetwise Reports  (7/19/17)
News about progress in two of this biotech's development programs prompted a rating upgrade by analyst Adam Walsh of Stifel Nicolaus & Company. More >

US Uranium Company Advances Its Assets
Source: Streetwise Reports  (7/18/17)
With core drilling and underground development nearly complete at its Canyon Mine and progress noted in other aspects of this company's business, Rodman & Renshaw analyst Heiko Ihle provided an update to investors. More >

Biotech with Alzheimer's Focus Makes Progress on Several Fronts
Source: Streetwise Reports  (7/18/17)
In its corporate update for Q2/17, a Canada-based biotech targeting neurological disorders including Alzheimer's disease informed investors of advancements in several programs, including designation of a second validated lead compound in development. More >

Auryn Begins World-Class Exploration on Seven Properties
Source: Bob Moriarty for Streetwise Reports  (7/17/17)
Bob Moriarty of 321Gold explores the prospects of a company he believes is run by a "dream team" that has assembled a stable of world-class projects.
More >

The Fed's Nightmare Scenario
Source: Lior Gantz for Streetwise Reports  (7/16/17)
Lior Gantz, founder of Wealth Research Group, analyzes how inflation will likely take off in the U.S., and why the condensed energy dammed up by the QE programs and the Fed asset purchases will explode all at once. More >

Gold: Cheaper Than Buying Greek Villas in 2012
Source: Tom Beck for Streetwise Reports  (7/16/17)
Tom Beck, founder of Portfolio Wealth Global, delves into the factors that drive gold investment demand. More >

The Biggest Opportunity in Precious Metals Since Late 2015, and the Last Chance at These Prices
Source: Clive Maund for Streetwise Reports  (7/15/17)
Technical analyst Clive Maund's analysis of the charts is indicating that gold and silver are positioning for a big move upward. More >

Jack Chan Charts New Low in Speculation in Precious Metals Markets
Source: Jack Chan for Streetwise Reports  (7/15/17)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets, noting new lows in speculative positions, which should boost prices.
More >

Is this Gold-Silver Royalty Company Poised to Rally?
Source: Peter Epstein for Streetwise Reports  (7/14/17)
Peter Epstein of Epstein Research explains why he believes the pieces are falling into place for this royalty and streaming company. More >

2017 Small-Cap Biotech Watchlist Update: Up 21% at the End of Q2/17
Source: Streetwise Reports  (7/13/17)
If an investor had purchased an equal dollar amount of each company on The Life Sciences Report's 2017 Small-Cap Biotech Watchlist at the beginning of the year, that portfolio would show a gain of about 21% as of July. This is primarily due to the performance of a handful of companies that have been moving their assets farther down the development pipeline, according to the analysts who follow them. More >

Frank Giustra Builds Another Gold Producer
Source: The Critical Investor for Streetwise Reports  (7/13/17)
The Critical Investor discusses a proposed business combination that would transform an explorer into a developing producer with major assets in Nevada. More >

Steady Progress Pushes Canadian Explorer to Dig Deeper and Expand in Mexico
Source: Streetwise Reports  (7/13/17)
An updated resource estimate and PEA in Q3/17 by a large exploration company will include plans for expansion after steady progress and a recent high-grade discovery at its Mexico project. More >

Has Novo Discovered the Wits West?
Source: Bob Moriarty for Streetwise Reports  (7/13/17)
Bob Moriarty of 321 Gold discusses the potential for Novo Resources to have a Witwatersrand-style deposit and the recent run-up in the explorer's stock. More >